Dashboard
Manage Tickers

CRMDCorMedix Inc.

Nasdaq cormedix.com


$ 5.10 $ -0.07 (-1.36 %)    

Monday, 10-Jun-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 464.61 $ 1.87 (0.4 %)
DIA $ 389.34 $ 0.80 (0.21 %)
SPY $ 535.72 $ 1.65 (0.31 %)
TLT $ 90.89 $ -0.61 (-0.67 %)
GLD $ 213.56 $ 1.94 (0.92 %)
$ 5.09
$ 5.11
$ 0.00 x 0
$ 0.00 x 0
$ 5.09 - $ 5.17
$ 2.57 - $ 7.00
347,345
na
279.74M
$ 1.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-12-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-29-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-19-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cormedix-announces-cms-grants-pass-through-status-for-defencath-under-hospital-outpatient-prospective-payment-system-opps
CorMedix Announces CMS Grants Pass-Through...
06/06/2024 12:34:09

cormedix-announces-commercial-agreement-with-top-tier-dialysis-provider-for-the-supply-of-defencath
CorMedix Announces Commercial Agreement Wi...
05/28/2024 12:43:16

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

needham-reiterates-buy-on-cormedix-maintains-10-price-target
Needham Reiterates Buy on Cormedix, Mainta...
05/13/2024 09:32:37

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-q1-2024-gaap-eps-025-beats-028-estimate-cash-and-equivalents-of-586m
Cormedix Q1 2024 GAAP EPS $(0.25) Beats $(...
05/09/2024 11:36:03

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.28) by 1...

cormedix-inc-announces-cms-grants-transitional-drug-add-on-payment-to-defencath
CorMedix Inc. Announces CMS Grants Transit...
04/19/2024 12:31:44

cormedix-announces-us-inpatient-commercial-availability-of-defencath
CorMedix Announces U.S. Inpatient Commerci...
04/15/2024 12:40:19

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
04/12/2024 20:31:04

two-of-cormedix-abstracts-accepted-for-presentation-at-shea-conference
Two Of CorMedix Abstracts Accepted For Pre...
04/11/2024 12:37:54

jmp-securities-reiterates-market-outperform-on-cormedix-maintains-19-price-target
JMP Securities Reiterates Market Outperfor...
04/09/2024 12:39:35

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

needham-reiterates-buy-on-cormedix-maintains-10-price-target
Needham Reiterates Buy on Cormedix, Mainta...
04/09/2024 10:08:10

Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-inc-announces-5-year-contract-with-dialysis-provider-arc-dialysis-for-the-supply-of-defencath
CorMedix Inc. Announces 5-Year Contract Wi...
04/08/2024 12:41:21

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseas...

rbc-capital-maintains-outperform-on-cormedix-lowers-price-target-to-9
RBC Capital Maintains Outperform on Cormed...
03/13/2024 14:57:29

RBC Capital analyst Gregory Renza maintains Cormedix (NASDAQ:CRMD) with a Outperform and lowers the price target from $10 to...

needham-maintains-buy-on-cormedix-maintains-10-price-target
Needham Maintains Buy on Cormedix, Maintai...
03/12/2024 20:35:12

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and maintains $10 price target.

cormedix-q4-gaap-eps-026-misses-020-estimate-cash-and-short-term-investments-of-76m
Cormedix Q4 GAAP EPS $(0.26) Misses $(0.20...
03/12/2024 11:33:04

Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.20) by...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

cormedix-earnings-preview
Cormedix Earnings Preview
03/11/2024 18:01:18

truist-securities-maintains-buy-on-cormedix-lowers-price-target-to-14-report-released-on-30-january-2024
Truist Securities Maintains Buy on Cormedi...
01/31/2024 18:43:54

Truist Securities analyst Joon Lee maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $18 to $14.

cormedix-inc-announces-commercial-and-operational-updates-related-to-its-business-and-anticipated-launch-of-defencath
CorMedix Inc. Announces Commercial And Ope...
01/08/2024 13:54:31

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

cormedix-inc-announces-partnership-with-the-leapfrog-group
CorMedix Inc. Announces Partnership With T...
12/04/2023 13:36:10

– CorMedix to advocate for patient safety and infection prevention as part of Leapfrog's Partners Advisory CommitteeBERKELE...

why-cormedix-stock-popped-wednesday
Why CorMedix Stock Popped Wednesday
11/15/2023 21:12:35

CorMedix Inc. (NASDAQ: CRMD) shares traded higher Wednesday after the company reported better-than-expected third-quarter earni...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)